Tag: Coronavirus

March 4, 2020

Alnylam Pharmaceuticals and Vir Biotechnology have teamed up to develop RNAi therapeutics against the coronavirus behind the COVID-19 outbreak. The collaboration builds on Alnylam synthesis of siRNAs that target highly conserved regions of coronavirus RNA. Vir and Alnylam joined forces […]

March 2, 2020

As previously communicated, the FDA has been monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S. […]

February 28, 2020

Virus containment measures imposed by the Chinese government have resulted in shutdowns or partial closures at manufacturing plants in Wuhan, the province in which the new coronavirus emerged, as well as other nearby areas. For the drug industry, sustained reductions […]

February 28, 2020

An international team of clinicians and researchers has had an unprecedented opportunity to examine what is likely to represent the early pathology of SARS-CoV-2 coronavirus in humans before symptoms develop. In an article, to be published in the Journal of […]

February 27, 2020

Clinical study of remdesivir has accelerated rapidly as health authorities and the biotech respond to the fast-spreading coronavirus epidemic, which has now spread to 37 countries. For the China studies and the NIH trial, Gilead has donated supplies of remdesivir […]

February 27, 2020

Publication in early January of the genetic make-up to SARS-CoV-2 catalyzed research efforts across the globe, in academic as well as biotech and pharmaceutical company laboratories. Nearly 20 groups are now developing coronavirus vaccines, including Johnson & Johnson and, more […]

February 27, 2020

A Sandoz spokesperson confirmed to BioPharma Dive that the company conducted an internal assessment of its marketed products to come up with a list of “essential” drugs that could help patients infected with SARS-CoV-2. The list includes priority antibiotics, hospital […]

February 27, 2020

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients today announced that it has released the first batch of mRNA-1273, the Company’s vaccine […]